UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Oncotarget, ISSN 1949-2553, 04/2016, Volume 7, Issue 15, pp. 19738 - 19747
PD-L1 | NSCLC | Anti-PD1/PD-L1 MoAbs | Immunotherapy | Predictive biomarker | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Immunohistochemistry | Outcome Assessment (Health Care) - methods | Lung Neoplasms - drug therapy | Prognosis | Humans | Lung Neoplasms - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Antineoplastic Agents | Antibodies, Monoclonal - therapeutic use | B7-H1 Antigen - immunology | Outcome Assessment (Health Care) - statistics & numerical data | B7-H1 Antigen - biosynthesis | Carcinoma, Non-Small-Cell Lung - drug therapy | Odds Ratio | Biomarkers, Tumor - biosynthesis | Index Medicus
Journal Article
Journal of hematology and oncology, 04/2017, Volume 10, Issue 1
Journal Article
Advanced materials (Weinheim), ISSN 0935-9648, 10/2016, Volume 28, Issue 40, pp. 8912 - 8920
anti‐PD1 | nanobiotechnology | CpG | drug delivery | cancer immunotherapy | anti-PD1 | Materials Science | Materials Science, Multidisciplinary | Physics, Condensed Matter | Science & Technology - Other Topics | Chemistry, Physical | Physics | Science & Technology | Physics, Applied | Physical Sciences | Chemistry | Nanoscience & Nanotechnology | Technology | Chemistry, Multidisciplinary | Neoplasms - therapy | Animals | Adjuvants, Immunologic | Immunotherapy | Antibodies | CpG Islands | Inflammation | Mice | Programmed Cell Death 1 Receptor - immunology | Drugs | Viral antibodies | Care and treatment | Drug delivery systems | Drug therapy | Cancer | Vehicles | Index Medicus | Immune systems | Inflammatory response | Nanostructure | Survival | Controlled release
Journal Article
Geburtshilfe und Frauenheilkunde, ISSN 0016-5751, 11/2018, Volume 78, Issue 11, pp. 1110 - 1118
GebFra Science | Prevention | Studies | Treatment | CDK4/6 | PD1/PDL1 | Risk | Breast cancer | Metastases | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | PDL1, Studien | treatment | Prävention | PDL1, studies | Metastasen | breast cancer | metastases | 6, PD1 | CDK4 | Mammakarzinom | risk | Behandlung | Risiko | prevention
Journal Article
Health science journal of Indonesia, ISSN 2087-7021, 07/2019, Volume 10, Issue 1, pp. 1 - 7
Journal Article
Radiotherapy and oncology, ISSN 0167-8140, 01/2021, Volume 154, pp. 125 - 127
Journal Article
7.
Full Text
Exacerbation of myasthenia gravis in a patient with melanoma treated with pembrolizumab
Muscle & nerve, ISSN 0148-639X, 07/2016, Volume 54, Issue 1, pp. 157 - 161
myasthenia gravis | pembrolizumab | melanoma | anti‐PD1 | immune checkpoint inhibitor | autoimmune adverse effect | anti-PD1 | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Melanoma - complications | Myasthenia Gravis - complications | Antineoplastic Agents - adverse effects | Humans | Melanoma - drug therapy | Male | Aged | Myasthenia Gravis - chemically induced | Monoclonal antibodies | Care and treatment | Myasthenia gravis | Immunotherapy | Melanoma | Skin cancer | Index Medicus
Journal Article
The oncologist (Dayton, Ohio), ISSN 1083-7159, 10/2018, Volume 23, Issue 10, pp. 1236 - 1241
Journal Article
Journal of immunotherapy (1997), ISSN 1524-9557, 11/2014, Volume 38, Issue 1, pp. 37 - 39
Arthritis | Anti-PD1 antibody | PD1 | Immunotherapy | Melanoma | Oncology | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Antibodies, Monoclonal, Humanized - adverse effects | Arthritis - chemically induced | Antineoplastic Agents - adverse effects | Humans | Melanoma - drug therapy | Middle Aged | Female | Male | Aged | Tenosynovitis - chemically induced | Index Medicus
Journal Article
10.
Full Text
Myopathie inflammatoire oculo-bulbaire et respiratoire après traitement par pembrolizumab
Revue neurologique, ISSN 0035-3787, 04/2018, Volume 174, pp. S42 - S42
Journal Article
Revue neurologique, ISSN 0035-3787, 04/2018, Volume 174, pp. S57 - S58
Journal Article
Oncotarget, ISSN 1949-2553, 02/2017, Volume 8, Issue 31, pp. 51936 - 51945
PD-L1 | B7-H1 | PD1 | PDL1 | Cancer | Oncology | Life Sciences & Biomedicine | Science & Technology | Cell Biology
Journal Article
12/2018, Advances in Experimental Medicine and Biology, ISBN 3030025047, Volume 995
Book Chapter
Journal for immunotherapy of cancer, ISSN 2051-1426, 01/2018, Volume 6, Issue 1, pp. 9 - 9
Checkpoint inhibitor | MRCC | Non-clear cell renal cell carcinoma | Immunotherapy | Nivolumab | PD1/PDL1 pathway | Oncology | Immunology | Life Sciences & Biomedicine | Science & Technology | Complications and side effects | Development and progression | Care and treatment | Carcinoma, Renal cell | Metastasis | Index Medicus | mRCC
Journal Article
Experimental cell research, ISSN 0014-4827, 11/2020, Volume 396, Issue 1, pp. 112244 - 112244
Journal Article